Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial

Autologous haematopoietic stem-cell transplantation (HSCT) in first remission is the current standard treatment in fit patients with mantle cell lymphoma. In this long-term follow-up study, we aimed to evaluate the efficacy of autologous HSCT versus interferon alfa maintenance after chemotherapy wit...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Lancet. Haematology 2021-09, Vol.8 (9), p.e648-e657
Hauptverfasser:	Zoellner, Anna-Katharina, Unterhalt, Michael, Stilgenbauer, Stephan, Hübel, Kai, Thieblemont, Catherine, Metzner, Bernd, Topp, Max, Truemper, Lorenz, Schmidt, Christian, Bouabdallah, Kamal, Krauter, Jürgen, Lenz, Georg, Dürig, Jan, Vergote, Vibeke, Schäfer-Eckart, Kerstin, André, Marc, Kluin-Nelemans, Hanneke C, van Hoof, Achiel, Klapper, Wolfram, Hiddemann, Wolfgang, Dreyling, Martin, Hoster, Eva
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!